Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults

Katia J. Bruxvoort, Bradley Ackerson, Lina S. Sy, Amit Bhavsar, Hung Fu Tseng, Ana Florea, Yi Luo, Yun Tian, Zendi Solano, Robyn Widenmaier, Meng Shi, Robbert Van Der Most, Johannes Eberhard Schmidt, Jasur Danier, Thomas Breuer, Lei Qian
doi: https://doi.org/10.1101/2021.10.01.21264400

Data Availability

The study details (GSK study number 217021) are available on the GSK Clinical Study Register and can be accessed at www.gskclinicalstudyregister.com.

https://www.gsk-studyregister.com/en/trial-details/?id=217021

Back to top
Posted October 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults
Katia J. Bruxvoort, Bradley Ackerson, Lina S. Sy, Amit Bhavsar, Hung Fu Tseng, Ana Florea, Yi Luo, Yun Tian, Zendi Solano, Robyn Widenmaier, Meng Shi, Robbert Van Der Most, Johannes Eberhard Schmidt, Jasur Danier, Thomas Breuer, Lei Qian
medRxiv 2021.10.01.21264400; doi: https://doi.org/10.1101/2021.10.01.21264400
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area